Ann Clin Hepatol | Volume 2, Issue 1 | Case Report | Open Access

Prognosis and Causes of Death in Individuals with Hepatitis C

Kazuo Okumoto*, Takafumi Saito, Taketo Nishina, Kei Mizuno, Kyoko Tomita, Hiroaki Haga and Yoshiyuki Ueno

Department of Gastroenterology, Yamagata University School of Medicine, Japan

*Correspondance to: Kazuo Okumoto 

Fulltext PDF

Abstract

Many patients with Hepatitis C Virus (HCV) infection show progression to chronic hepatitis. About 30% of HCV infected individuals are known to show natural resolution in the acute phase of infection. However, the long-term prognosis after HCV eradication is unknown. We show the outcomes and causes of death of HCV-infected patients. The subjects were 1115 individuals who tested positive for anti-HCV antibody between 1991 and 2016. 346 patients were HCV RNA-negative and 721 were positive. The average age at death for hepatitis C-infected individuals was 79.5 ± 8.1 years. The average age at death among individuals who showed spontaneous resolution of hepatitis C was 79.4 ± 9.2 years. In this group, the causes of death included liver-related disease (6%; 65.3 ± 9.6 years), cancers other than natural resolution (24.7%; 77.4 ± 7.5 years), pneumonia (20.3%; 84.2 ± 5.9 years), cerebrovascular disease (13.7%; 76.8 ± 11.2 years), heart disease (11.5%; 78.2 ± 9.1 years), renal disease (1.1%; 79.5 ± 6.4 years old), and others (22.5%; 82.7 ± 7.9 years). Patients with HCC died at a relatively young age (65.3 ± 9.6 years) compared with the others.The results of the present study suggest that even if the hepatitis C virus has been undetectable for a long period of time, the incidence of liver cancer is nevertheless higher than usual, and therefore the reasons for this require further investigation.

Keywords:

Hepatitis C virus; Natural resolution; Direct acting antivirals; Hepato cellular carcinoma

Citation:

Okumoto K, Saito T, Nishina T, Mizuno K, Tomita K, Haga H, et al. Prognosis and Causes of Death in Individuals with Hepatitis C. Ann Clin Hepatol. 2018; 2(1): 1006.

Subscribe to Our Newsletter